Centocor Inc enter agreement Ajinomoto Co Inc> exclusive distribution Centocor's Panorex Japan. Panorex monoclonal antibody recombinant gene technology treatment pancreatic cancer. It test human Europe U.S. 1982. Centocor intend begin clinical trial U.S. modify form drug. Under agreement Ajinomoto conduct clinical test drug Japan company jointly file marketing approval product Japan. Reuter 